Today: 30 April 2026
Apple stock slides into earnings: why AAPL traders brace for a bumpier week
17 January 2026
1 min read

Apple stock slides into earnings: why AAPL traders brace for a bumpier week

New York, January 17, 2026, 09:36 EST — Market closed.

  • Shares of Apple slipped 1.1% by Friday’s close.
  • Traders warn that the holiday-shortened week after monthly options expiration often sparks bigger market swings.
  • Apple will release its quarterly results on Jan. 29, with investors watching closely for updates on iPhone demand, profit margins, and expenses.

Apple shares dipped on Friday as investors head into a holiday-shortened week, with the iPhone maker’s earnings report looming in under two weeks.

Apple slipped 1.1% to finish at $255.53 on Friday, putting its market cap near $3.0 trillion.

That’s significant since U.S. stocks have been trapped in a tight range close to record highs, and the focus is shifting from bank earnings to the megacap tech giants that drive indexes and risk sentiment. A major move in Apple could pull the entire market along.

Wall Street closed almost unchanged on Friday ahead of the long weekend, with the Nasdaq and S&P 500 slipping roughly 0.1%. Markets will be closed Monday in observance of Martin Luther King Jr. Day.

Friday’s monthly options expiration often shakes up trading, and some traders are bracing for more volatility afterward. The event can shift how options dealers manage their hedges, which then ripples through daily stock movements.

“I think this options expiration will allow the S&P 500 to start moving around a bit more,” said Brent Kochuba, founder of options analytics service SpotGamma. Reuters

He referred to “gamma,” the options term for how fast a dealer’s hedge must shift as prices change. Dealers who are “long gamma” tend to buy on dips and sell into rallies, which usually smooths out volatility. But when that stance fades, price swings can grow more extreme.

Mike Khouw, strategist at YieldMax ETFs, noted that single-stock options might gain even more importance as earnings season heats up, with traders focusing on company-specific moves instead of broad index shifts.

Apple is facing fresh scrutiny over cost pressures amid talk of volatility. A Bloomberg story out this week highlighted soaring memory prices, posing a rising threat to hardware makers like Apple. If companies can’t shift these higher component costs onto customers, margins could take a hit.

Apple’s quarterly report on Jan. 29 is the more immediate hard date. Investors will focus on management’s take on holiday-quarter demand and if gross margin can withstand rising component costs.

A major risk is that earnings season triggers a shift in expectations. Should Apple offer a cautious outlook—whether on demand, costs, or both—investors might pull back from valuing the stock so highly, especially since it’s been a stand-in for the broader market in recent years.

Next up: the market reopens Tuesday, with traders bracing for bigger index moves following options expiration and tracking Apple’s positioning ahead of its Jan. 29 earnings release.

Stock Market Today

  • Biogen Shares Rise 6% After Q1 Earnings Beat Despite Guidance Cut
    April 29, 2026, 9:29 PM EDT. Biogen (NASDAQ: BIIB) shares rose 6% on Wednesday following its first-quarter 2026 earnings report. The biotech posted $2.48 billion in revenue, surpassing analyst expectations of $2.25 billion. Net income, excluding accounting standards (GAAP), increased 19% to over $529 million, or $3.57 per share, above forecasts of $2.95. Growth was driven by strong sales of Leqembi, for early Alzheimer's, up 74%, and the FDA-approved Skyclarys for Friedreich's ataxia. However, Biogen cut full-year adjusted net income guidance by $1 per share citing research and development charges. Revenue is expected to decline mid-single digits from 2025, excluding a pending $5.6 billion acquisition of Apellis Pharmaceuticals. Biogen's strategic shift towards high-potential therapies is underway despite cautious outlook.

Latest article

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

30 April 2026
Soluna Holdings filed to register the resale of about 2.46 million common shares, with no proceeds going to the company. The move follows Sazmining’s launch of a 3-megawatt Bitcoin mining operation at Soluna’s Project Dorothy 1B in West Texas. Soluna shares last traded at $1.28, up from a $1.08 Nasdaq sale price on April 28. The registered shares include 2.4 million issuable to YA II PN, LTD. via warrant exercise.
Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

30 April 2026
Brookfield Renewable Corp’s NYSE shares fell 12.5% to $35.20 on Wednesday, with volume quadrupling the three-month average ahead of first-quarter results due Friday. The drop came despite a higher quarterly dividend and mixed analyst views. The company operates 47 GW of clean energy assets globally. Analysts expect a first-quarter loss of 33.92 cents per share on $1.62 billion in revenue.
AST SpaceMobile stock spikes on $151 billion SHIELD defense pool nod — what to watch next week
Previous Story

AST SpaceMobile stock spikes on $151 billion SHIELD defense pool nod — what to watch next week

Eli Lilly stock price in focus as FDA slips obesity pill deadline — what to watch in LLY next week
Next Story

Eli Lilly stock price in focus as FDA slips obesity pill deadline — what to watch in LLY next week

Go toTop